Consensus or Controversy, Issue 5: Palliative Care

Subscription | Change of Address

If you already receive our audio, print or email programs and need to update your mailing address or email address, please fill out the form below. Subscriptions to our mailed programs are available free of charge to practicing clinicians in the United States. Select programs may be available for international clinicians. Emails and web content are available to all users.

If you are not a current subscriber but would like to receive our programs, click here.

To cancel an existing subscription, click here.

Consensus or Controversy, Issue 4: EGFR Mutation/TKIs

Consensus or Controversy, Issue 3: Adjuvant Chemotherapy

Consensus or Controversy, Issue 2: Chemo for Advanced NSCLC

Consensus or Controversy, Issue 1: Tissue Assays in NSCLC

Year in Review – Multiple Myeloma: 2009-2010

Finding the Positives in Triple-Negative Breast Cancer

Efficacy and Safety of Bevacizumab with Capecitabine and Cisplatin in Patients with Advanced Gastric Cancer

Cetuximab with Chemotherapy as Treatment for Stage III Colon or Metastatic Colorectal Cancer

Use of Bevacizumab in the Neoadjuvant Setting for Patients with Locally Advanced Rectal Cancer

Use of Bevacizumab in the Maintenance Setting for Patients with Metastatic Colorectal Cancer (mCRC)

Efficacy and Safety of FOLFIRINOX in Patients with Metastatic Pancreatic Cancer

5-Minute Journal Club — ASCO 2010 Presentations

5-Minute Journal Club — ASCO 2010 Presentations

 

Carboplatin and Paclitaxel as Therapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

Syndicate content